FDA approves Zelboraf (vemurafenib) and companion diagnostic for BRAF mutation-positive metastatic melanoma, a deadly form of skin cancer
First and only personalized medicine shown to help people with BRAF V600E mutation-positive metastatic melanoma, found in half of melanoma patients, live longer.
Generous Eckenstein-Geigy Foundation facilitates research in paediatric medicine
The Eckenstein-Geigy Foundation is sponsoring the urgently needed research and development of medicines for children and adolescents to the tune of 15 million francs. For ten years initially an Eckenstein-Geigy Research Professor...
Basel Technology Park – the new address for young technology companies in Basel North
Starting in June 2011, the Basel Technology Park will offer young, innovative companies flexible office and laboratory space. Young companies here have the opportunity to work, research and exchange ideas with other companies...
Evolva to Acquire Abunda Nutrition
The Basel based company announces today that it plans to acquire its R&D partner Abunda Nutrition, Inc.
BioVersys raises CHF 2.5 millions in a Seed Financing round
BioVersys AG is pleased to announce the closing of a seed financing round of CHF 2.5 millions. With this, BioVersys has taken the first step towards the development of novel therapies to overcome bacterial resistance against...